Brendan Smith
Stock Analyst at TD Cowen
(1.15)
# 3,757
Out of 5,163 analysts
16
Total ratings
36.36%
Success rate
-3.74%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNA Ginkgo Bioworks Holdings | Maintains: Buy | $14 → $12 | $6.80 | +76.47% | 2 | Jan 8, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $32 → $43 | $43.28 | -0.65% | 1 | Jan 8, 2026 | |
| SLP Simulations Plus | Maintains: Hold | $16 → $19 | $12.44 | +52.73% | 2 | Jan 8, 2026 | |
| SDGR Schrödinger | Maintains: Buy | $33 → $24 | $12.51 | +91.85% | 1 | Jan 8, 2026 | |
| CTKB Cytek Biosciences | Maintains: Buy | $4 → $5 | $4.01 | +24.69% | 1 | Jan 8, 2026 | |
| AZTA Azenta | Maintains: Hold | $35 → $39 | $21.42 | +82.07% | 1 | Jan 8, 2026 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $79 → $90 | $63.66 | +41.38% | 3 | Jan 8, 2026 | |
| NVAX Novavax | Maintains: Hold | $8 → $7 | $10.24 | -31.61% | 2 | Nov 4, 2025 | |
| WST West Pharmaceutical Services | Initiates: Buy | $350 | $235.46 | +48.65% | 1 | Oct 29, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Outperform | n/a | $55.05 | - | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $20.57 | - | 1 | Dec 5, 2022 |
Ginkgo Bioworks Holdings
Jan 8, 2026
Maintains: Buy
Price Target: $14 → $12
Current: $6.80
Upside: +76.47%
Twist Bioscience
Jan 8, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $43.28
Upside: -0.65%
Simulations Plus
Jan 8, 2026
Maintains: Hold
Price Target: $16 → $19
Current: $12.44
Upside: +52.73%
Schrödinger
Jan 8, 2026
Maintains: Buy
Price Target: $33 → $24
Current: $12.51
Upside: +91.85%
Cytek Biosciences
Jan 8, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $4.01
Upside: +24.69%
Azenta
Jan 8, 2026
Maintains: Hold
Price Target: $35 → $39
Current: $21.42
Upside: +82.07%
Halozyme Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $79 → $90
Current: $63.66
Upside: +41.38%
Novavax
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $10.24
Upside: -31.61%
West Pharmaceutical Services
Oct 29, 2025
Initiates: Buy
Price Target: $350
Current: $235.46
Upside: +48.65%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $55.05
Upside: -
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $20.57
Upside: -